Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Copper Based Antibacterial Compounds: Potential Targeting Pathways and Current Drug Design Trends.

Version 1 : Received: 27 April 2023 / Approved: 28 April 2023 / Online: 28 April 2023 (05:38:16 CEST)
Version 2 : Received: 23 May 2023 / Approved: 23 May 2023 / Online: 23 May 2023 (08:01:12 CEST)

A peer-reviewed article of this Preprint also exists.

Orta-Rivera, A.M.; Meléndez-Contés, Y.; Medina-Berríos, N.; Gómez-Cardona, A.M.; Ramos-Rodríguez, A.; Cruz-Santiago, C.; González-Dumeng, C.; López, J.; Escribano, J.; Rivera-Otero, J.J.; Díaz-Rivera, J.; Díaz-Vélez, S.C.; Feliciano-Delgado, Z.; Tinoco, A.D. Copper-Based Antibiotic Strategies: Exploring Applications in the Hospital Setting and the Targeting of Cu Regulatory Pathways and Current Drug Design Trends. Inorganics 2023, 11, 252. Orta-Rivera, A.M.; Meléndez-Contés, Y.; Medina-Berríos, N.; Gómez-Cardona, A.M.; Ramos-Rodríguez, A.; Cruz-Santiago, C.; González-Dumeng, C.; López, J.; Escribano, J.; Rivera-Otero, J.J.; Díaz-Rivera, J.; Díaz-Vélez, S.C.; Feliciano-Delgado, Z.; Tinoco, A.D. Copper-Based Antibiotic Strategies: Exploring Applications in the Hospital Setting and the Targeting of Cu Regulatory Pathways and Current Drug Design Trends. Inorganics 2023, 11, 252.

Abstract

Classical antibacterial drugs were designed to target specific bacterial properties distinct from host human cells to maximize potency and selectivity. These designs were quite effective as they could be easily derivatized to bear next generation drugs. However, the rapid mutation of bacteria and their associated acquired drug resistance have led to the rise of highly pathogenic superbug bac-terial strains for which treatment with first line drugs is no match. More than ever, there is a dire need for antibacterial drug design that goes beyond conventional standards. Taking inspiration by the body’s innate immune response to employ its own supply of labile copper ions in a toxic attack against pathogenic bacteria, which have a very low Cu tolerance, this review article examines the feasibility of Cu-centric strategies for antibacterial preventative and therapeutic applications. Promising results are shown for the use of Cu-containing materials in the hospital setting to minimize patient bacterial infections. Studies directed at disrupting bacterial Cu regulatory pathways elucidate new drug targets that can enable toxic increase of Cu levels and perturb bac-terial dependence on iron. Likewise, Cu intracellular chelation/prochelation strategies effectively induce bacterial Cu toxicity. Cu-based small molecules and nanoparticles demonstrate the im-portance of the Cu ions in their mechanism and display potential synergism with classical drugs.

Keywords

copper coordination; copper homeostasis; antibacterial; antibiotic.

Subject

Chemistry and Materials Science, Other

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.